false00017347222022Q201-31http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent00017347222021-02-012021-07-31xbrli:shares0001734722us-gaap:CommonClassAMember2021-09-030001734722us-gaap:CommonClassBMember2021-09-03iso4217:USD00017347222021-07-3100017347222021-01-31iso4217:USDxbrli:shares0001734722us-gaap:CommonClassAMember2021-01-310001734722us-gaap:CommonClassAMember2021-07-310001734722us-gaap:CommonClassBMember2021-01-310001734722us-gaap:CommonClassBMember2021-07-310001734722us-gaap:LicenseMember2021-05-012021-07-310001734722us-gaap:LicenseMember2020-05-012020-07-310001734722us-gaap:LicenseMember2021-02-012021-07-310001734722us-gaap:LicenseMember2020-02-012020-07-310001734722path:MaintenanceAndSupportMember2021-05-012021-07-310001734722path:MaintenanceAndSupportMember2020-05-012020-07-310001734722path:MaintenanceAndSupportMember2021-02-012021-07-310001734722path:MaintenanceAndSupportMember2020-02-012020-07-310001734722path:ServicesAndOtherMember2021-05-012021-07-310001734722path:ServicesAndOtherMember2020-05-012020-07-310001734722path:ServicesAndOtherMember2021-02-012021-07-310001734722path:ServicesAndOtherMember2020-02-012020-07-3100017347222021-05-012021-07-3100017347222020-05-012020-07-3100017347222020-02-012020-07-310001734722us-gaap:ConvertiblePreferredStockMember2021-01-310001734722us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-01-310001734722us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-01-310001734722us-gaap:AdditionalPaidInCapitalMember2021-01-310001734722us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-310001734722us-gaap:RetainedEarningsMember2021-01-310001734722us-gaap:ConvertiblePreferredStockMember2021-02-012021-04-300001734722us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-02-012021-04-300001734722us-gaap:AdditionalPaidInCapitalMember2021-02-012021-04-3000017347222021-02-012021-04-300001734722us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-02-012021-04-300001734722us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-02-012021-04-300001734722us-gaap:RetainedEarningsMember2021-02-012021-04-300001734722us-gaap:ConvertiblePreferredStockMember2021-04-300001734722us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-04-300001734722us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-04-300001734722us-gaap:AdditionalPaidInCapitalMember2021-04-300001734722us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-300001734722us-gaap:RetainedEarningsMember2021-04-3000017347222021-04-300001734722us-gaap:AdditionalPaidInCapitalMember2021-05-012021-07-310001734722us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-05-012021-07-310001734722us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-05-012021-07-310001734722us-gaap:RetainedEarningsMember2021-05-012021-07-310001734722us-gaap:ConvertiblePreferredStockMember2021-07-310001734722us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-07-310001734722us-gaap:CommonClassBMemberus-gaap:CommonStockMember2021-07-310001734722us-gaap:AdditionalPaidInCapitalMember2021-07-310001734722us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-310001734722us-gaap:RetainedEarningsMember2021-07-310001734722us-gaap:ConvertiblePreferredStockMember2020-01-310001734722us-gaap:CommonStockMemberus-gaap:CommonClassAMember2020-01-310001734722us-gaap:CommonClassBMemberus-gaap:CommonStockMember2020-01-310001734722us-gaap:AdditionalPaidInCapitalMember2020-01-310001734722us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-310001734722us-gaap:RetainedEarningsMember2020-01-3100017347222020-01-310001734722us-gaap:CommonStockMemberus-gaap:CommonClassAMember2020-02-012020-04-300001734722us-gaap:AdditionalPaidInCapitalMember2020-02-012020-04-3000017347222020-02-012020-04-300001734722us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-02-012020-04-300001734722us-gaap:RetainedEarningsMember2020-02-012020-04-300001734722us-gaap:ConvertiblePreferredStockMember2020-04-300001734722us-gaap:CommonStockMemberus-gaap:CommonClassAMember2020-04-300001734722us-gaap:CommonClassBMemberus-gaap:CommonStockMember2020-04-300001734722us-gaap:AdditionalPaidInCapitalMember2020-04-300001734722us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-04-300001734722us-gaap:RetainedEarningsMember2020-04-3000017347222020-04-300001734722us-gaap:ConvertiblePreferredStockMember2020-05-012020-07-310001734722us-gaap:CommonStockMemberus-gaap:CommonClassAMember2020-05-012020-07-310001734722us-gaap:AdditionalPaidInCapitalMember2020-05-012020-07-310001734722us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-05-012020-07-310001734722us-gaap:RetainedEarningsMember2020-05-012020-07-310001734722us-gaap:ConvertiblePreferredStockMember2020-07-310001734722us-gaap:CommonStockMemberus-gaap:CommonClassAMember2020-07-310001734722us-gaap:CommonClassBMemberus-gaap:CommonStockMember2020-07-310001734722us-gaap:AdditionalPaidInCapitalMember2020-07-310001734722us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-310001734722us-gaap:RetainedEarningsMember2020-07-3100017347222020-07-31path:country0001734722us-gaap:IPOMemberus-gaap:CommonClassAMember2021-04-232021-04-230001734722us-gaap:IPOMemberus-gaap:CommonClassAMember2021-04-230001734722us-gaap:OverAllotmentOptionMemberus-gaap:CommonClassAMember2021-04-232021-04-230001734722us-gaap:IPOMemberus-gaap:CommonClassAMember2021-04-212021-04-210001734722us-gaap:OtherNoncurrentAssetsMember2021-01-310001734722us-gaap:IPOMember2021-04-232021-04-230001734722us-gaap:ForeignExchangeForwardMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2021-07-310001734722path:AccruedExpensesAndOtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeForwardMember2021-01-310001734722us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2021-07-310001734722us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2021-01-310001734722us-gaap:ForeignExchangeForwardMember2021-05-012021-07-310001734722us-gaap:ForeignExchangeForwardMember2021-02-012021-07-31xbrli:pure0001734722path:CashCashEquivalentsAndRestrictedCashMemberus-gaap:GeographicConcentrationRiskMemberpath:UnitedStatesEuropeanUnionEUCountriesAndJapanMember2021-02-012021-07-310001734722path:CashCashEquivalentsAndRestrictedCashMemberus-gaap:GeographicConcentrationRiskMemberpath:UnitedStatesEuropeanUnionEUCountriesAndJapanMember2020-02-012021-01-310001734722us-gaap:CustomerConcentrationRiskMemberpath:OneCustomerMemberus-gaap:AccountsReceivableMember2021-02-012021-07-310001734722srt:MinimumMember2021-02-012021-07-310001734722srt:MaximumMember2021-02-012021-07-31path:segment0001734722us-gaap:OtherNoncurrentAssetsMember2021-07-310001734722srt:AmericasMember2021-05-012021-07-310001734722us-gaap:RevenueFromContractWithCustomerMembersrt:AmericasMemberus-gaap:GeographicConcentrationRiskMember2021-05-012021-07-310001734722srt:AmericasMember2020-05-012020-07-310001734722us-gaap:RevenueFromContractWithCustomerMembersrt:AmericasMemberus-gaap:GeographicConcentrationRiskMember2020-05-012020-07-310001734722us-gaap:EMEAMember2021-05-012021-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:EMEAMember2021-05-012021-07-310001734722us-gaap:EMEAMember2020-05-012020-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:EMEAMember2020-05-012020-07-310001734722srt:AsiaPacificMember2021-05-012021-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMembersrt:AsiaPacificMember2021-05-012021-07-310001734722srt:AsiaPacificMember2020-05-012020-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMembersrt:AsiaPacificMember2020-05-012020-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2021-05-012021-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2020-05-012020-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMembercountry:US2021-05-012021-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMembercountry:US2020-05-012020-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMembercountry:JP2021-05-012021-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMembercountry:JP2020-05-012020-07-310001734722srt:AmericasMember2021-02-012021-07-310001734722us-gaap:RevenueFromContractWithCustomerMembersrt:AmericasMemberus-gaap:GeographicConcentrationRiskMember2021-02-012021-07-310001734722srt:AmericasMember2020-02-012020-07-310001734722us-gaap:RevenueFromContractWithCustomerMembersrt:AmericasMemberus-gaap:GeographicConcentrationRiskMember2020-02-012020-07-310001734722us-gaap:EMEAMember2021-02-012021-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:EMEAMember2021-02-012021-07-310001734722us-gaap:EMEAMember2020-02-012020-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:EMEAMember2020-02-012020-07-310001734722srt:AsiaPacificMember2021-02-012021-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMembersrt:AsiaPacificMember2021-02-012021-07-310001734722srt:AsiaPacificMember2020-02-012020-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMembersrt:AsiaPacificMember2020-02-012020-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2021-02-012021-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMember2020-02-012020-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMembercountry:US2021-02-012021-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMembercountry:US2020-02-012020-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMembercountry:JP2021-02-012021-07-310001734722us-gaap:RevenueFromContractWithCustomerMemberus-gaap:GeographicConcentrationRiskMembercountry:JP2020-02-012020-07-310001734722us-gaap:BilledRevenuesMember2021-07-310001734722us-gaap:UnbilledRevenuesMember2021-07-3100017347222021-08-012021-07-310001734722us-gaap:CommercialPaperMember2021-07-310001734722us-gaap:CorporateBondSecuritiesMember2021-07-310001734722us-gaap:CommercialPaperMember2021-01-310001734722us-gaap:CorporateBondSecuritiesMember2021-01-310001734722us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-07-310001734722us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-07-310001734722us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-07-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-07-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-07-310001734722us-gaap:FairValueMeasurementsRecurringMember2021-07-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel1Member2021-07-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Member2021-07-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2021-07-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-07-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel2Member2021-07-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2021-07-310001734722us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-01-310001734722us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-01-310001734722us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-01-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel1Member2021-01-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Member2021-01-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2021-01-310001734722us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-01-310001734722us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-01-310001734722us-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-01-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-01-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-01-310001734722us-gaap:FairValueMeasurementsRecurringMember2021-01-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel1Member2021-01-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Member2021-01-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2021-01-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-01-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMemberus-gaap:FairValueInputsLevel2Member2021-01-310001734722us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateBondSecuritiesMember2021-01-310001734722path:CloudElementsIncMember2021-03-192021-03-190001734722path:CloudElementsIncMember2021-03-190001734722path:CloudElementsIncMemberus-gaap:DevelopedTechnologyRightsMember2021-03-192021-03-190001734722path:CloudElementsIncMemberus-gaap:CustomerRelationshipsMember2021-03-192021-03-190001734722path:CloudElementsIncMemberus-gaap:TradeNamesMember2021-03-192021-03-190001734722path:CloudElementsIncMember2021-07-310001734722path:CloudElementsIncMemberus-gaap:GeneralAndAdministrativeExpenseMember2021-02-012021-07-310001734722us-gaap:DevelopedTechnologyRightsMember2021-07-310001734722us-gaap:DevelopedTechnologyRightsMember2021-02-012021-07-310001734722us-gaap:CustomerRelationshipsMember2021-07-310001734722us-gaap:CustomerRelationshipsMember2021-02-012021-07-310001734722us-gaap:TrademarksAndTradeNamesMember2021-07-310001734722us-gaap:TrademarksAndTradeNamesMember2021-02-012021-07-310001734722us-gaap:DevelopedTechnologyRightsMember2021-01-310001734722us-gaap:DevelopedTechnologyRightsMember2020-02-012021-01-310001734722us-gaap:CustomerRelationshipsMember2021-01-310001734722us-gaap:CustomerRelationshipsMember2020-02-012021-01-310001734722us-gaap:TrademarksAndTradeNamesMember2021-01-310001734722us-gaap:TrademarksAndTradeNamesMember2020-02-012021-01-310001734722srt:MinimumMember2021-07-310001734722srt:MaximumMember2021-07-310001734722us-gaap:ComputerEquipmentMember2021-07-310001734722us-gaap:ComputerEquipmentMember2021-01-310001734722us-gaap:LeaseholdImprovementsMember2021-07-310001734722us-gaap:LeaseholdImprovementsMember2021-01-310001734722us-gaap:FurnitureAndFixturesMember2021-07-310001734722us-gaap:FurnitureAndFixturesMember2021-01-310001734722us-gaap:PropertyPlantAndEquipmentOtherTypesMember2021-07-310001734722us-gaap:PropertyPlantAndEquipmentOtherTypesMember2021-01-310001734722path:SeniorSecuredCreditFacilityMember2020-07-012020-07-300001734722path:SeniorSecuredCreditFacilityMember2020-07-310001734722path:HSBCVenturesUSAIncSiliconValleyBankSumitomoMitsuiBankingCorporationAndMizuhoBankLTDMemberpath:SeniorSecuredCreditFacilityMember2020-10-300001734722path:HSBCVenturesUSAIncSiliconValleyBankSumitomoMitsuiBankingCorporationAndMizuhoBankLTDMemberpath:SeniorSecuredCreditFacilityMember2021-07-310001734722path:HSBCVenturesUSAIncSiliconValleyBankSumitomoMitsuiBankingCorporationAndMizuhoBankLTDMemberpath:SeniorSecuredCreditFacilityMember2021-01-310001734722path:AccruedExpensesAndOtherCurrentLiabilitiesMember2021-07-310001734722path:AccruedExpensesAndOtherCurrentLiabilitiesMember2021-01-310001734722path:SeriesFConvertiblePreferredStockMember2021-02-280001734722path:SeriesFConvertiblePreferredStockMember2021-04-220001734722us-gaap:CommonClassAMember2021-04-222021-04-220001734722us-gaap:CommonClassAMember2021-04-300001734722us-gaap:CommonClassBMember2021-04-300001734722srt:MinimumMember2021-04-012021-04-300001734722srt:MaximumMember2021-04-012021-04-30path:vote0001734722us-gaap:AccumulatedTranslationAdjustmentMember2021-01-310001734722us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-310001734722us-gaap:AccumulatedTranslationAdjustmentMember2021-02-012021-07-310001734722us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-02-012021-07-310001734722us-gaap:AccumulatedTranslationAdjustmentMember2021-07-310001734722us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-07-310001734722us-gaap:AccumulatedTranslationAdjustmentMember2020-01-310001734722us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-01-310001734722us-gaap:AccumulatedTranslationAdjustmentMember2020-02-012020-07-310001734722us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-02-012020-07-310001734722us-gaap:AccumulatedTranslationAdjustmentMember2020-07-310001734722us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-07-310001734722path:TwoThousandFifteenStockPlanMember2015-06-300001734722path:TwoThousandEighteenStockPlanMember2018-06-300001734722path:TwoThousandTwentyOneStockPlanMemberus-gaap:CommonClassAMember2021-04-220001734722path:TwoThousandTwentyOneStockPlanMember2021-04-012021-04-220001734722path:TwoThousandTwentyOneEmployeeStockPurchasePlanMember2021-04-220001734722path:TwoThousandTwentyOneEmployeeStockPurchasePlanMember2021-04-012021-04-220001734722path:TwoThousandTwentyOneEmployeeStockPurchasePlanMemberus-gaap:CommonClassAMember2021-04-212021-04-210001734722path:TwoThousandTwentyOneEmployeeStockPurchasePlanMembersrt:ScenarioForecastMemberus-gaap:CommonClassAMember2021-12-202021-12-200001734722path:TwoThousandTwentyOneEmployeeStockPurchasePlanMember2021-07-310001734722path:TwoThousandTwentyOneEmployeeStockPurchasePlanMember2021-02-012021-07-3100017347222020-02-012021-01-310001734722us-gaap:EmployeeStockOptionMember2021-02-012021-07-310001734722us-gaap:EmployeeStockOptionMember2020-02-012020-07-310001734722us-gaap:EmployeeStockOptionMember2021-07-310001734722path:EarlyExercisedOptionsMember2021-07-310001734722path:EarlyExercisedOptionsMember2021-01-310001734722us-gaap:RestrictedStockUnitsRSUMember2021-01-310001734722us-gaap:RestrictedStockUnitsRSUMember2021-02-012021-07-310001734722us-gaap:RestrictedStockUnitsRSUMember2021-07-310001734722us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonClassAMember2021-07-310001734722us-gaap:RestrictedStockUnitsRSUMember2020-02-012020-07-310001734722us-gaap:RestrictedStockUnitsRSUMember2021-04-232021-04-230001734722us-gaap:RestrictedStockMember2020-09-012020-09-300001734722us-gaap:RestrictedStockMember2021-07-310001734722us-gaap:RestrictedStockMember2021-02-012021-07-310001734722us-gaap:CostOfSalesMember2021-05-012021-07-310001734722us-gaap:CostOfSalesMember2020-05-012020-07-310001734722us-gaap:CostOfSalesMember2021-02-012021-07-310001734722us-gaap:CostOfSalesMember2020-02-012020-07-310001734722us-gaap:SellingAndMarketingExpenseMember2021-05-012021-07-310001734722us-gaap:SellingAndMarketingExpenseMember2020-05-012020-07-310001734722us-gaap:SellingAndMarketingExpenseMember2021-02-012021-07-310001734722us-gaap:SellingAndMarketingExpenseMember2020-02-012020-07-310001734722us-gaap:ResearchAndDevelopmentExpenseMember2021-05-012021-07-310001734722us-gaap:ResearchAndDevelopmentExpenseMember2020-05-012020-07-310001734722us-gaap:ResearchAndDevelopmentExpenseMember2021-02-012021-07-310001734722us-gaap:ResearchAndDevelopmentExpenseMember2020-02-012020-07-310001734722us-gaap:GeneralAndAdministrativeExpenseMember2021-05-012021-07-310001734722us-gaap:GeneralAndAdministrativeExpenseMember2020-05-012020-07-310001734722us-gaap:GeneralAndAdministrativeExpenseMember2021-02-012021-07-310001734722us-gaap:GeneralAndAdministrativeExpenseMember2020-02-012020-07-310001734722country:JP2021-07-310001734722us-gaap:CommonClassAMember2021-05-012021-07-310001734722us-gaap:CommonClassBMember2021-05-012021-07-310001734722us-gaap:CommonClassAMember2020-05-012020-07-310001734722us-gaap:CommonClassBMember2020-05-012020-07-310001734722us-gaap:CommonClassAMember2021-02-012021-07-310001734722us-gaap:CommonClassBMember2021-02-012021-07-310001734722us-gaap:CommonClassAMember2020-02-012020-07-310001734722us-gaap:CommonClassBMember2020-02-012020-07-310001734722us-gaap:ConvertiblePreferredStockMemberus-gaap:CommonClassAMember2021-05-012021-07-310001734722us-gaap:ConvertiblePreferredStockMemberus-gaap:CommonClassBMember2021-05-012021-07-310001734722us-gaap:ConvertiblePreferredStockMemberus-gaap:CommonClassAMember2020-05-012020-07-310001734722us-gaap:ConvertiblePreferredStockMemberus-gaap:CommonClassBMember2020-05-012020-07-310001734722us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonClassAMember2021-05-012021-07-310001734722us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonClassBMember2021-05-012021-07-310001734722us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonClassAMember2020-05-012020-07-310001734722us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonClassBMember2020-05-012020-07-310001734722us-gaap:EmployeeStockOptionMemberus-gaap:CommonClassAMember2021-05-012021-07-310001734722us-gaap:EmployeeStockOptionMemberus-gaap:CommonClassBMember2021-05-012021-07-310001734722us-gaap:EmployeeStockOptionMemberus-gaap:CommonClassAMember2020-05-012020-07-310001734722us-gaap:EmployeeStockOptionMemberus-gaap:CommonClassBMember2020-05-012020-07-310001734722us-gaap:CommonClassAMemberpath:SharesSubjectToRepurchaseFromRestrictedStockAwardsAndEarlyExercisedStockOptionsMember2021-05-012021-07-310001734722us-gaap:CommonClassBMemberpath:SharesSubjectToRepurchaseFromRestrictedStockAwardsAndEarlyExercisedStockOptionsMember2021-05-012021-07-310001734722us-gaap:CommonClassAMemberpath:SharesSubjectToRepurchaseFromRestrictedStockAwardsAndEarlyExercisedStockOptionsMember2020-05-012020-07-310001734722us-gaap:CommonClassBMemberpath:SharesSubjectToRepurchaseFromRestrictedStockAwardsAndEarlyExercisedStockOptionsMember2020-05-012020-07-310001734722us-gaap:EmployeeStockMemberus-gaap:CommonClassAMember2021-05-012021-07-310001734722us-gaap:EmployeeStockMemberus-gaap:CommonClassBMember2021-05-012021-07-310001734722us-gaap:EmployeeStockMemberus-gaap:CommonClassAMember2020-05-012020-07-310001734722us-gaap:EmployeeStockMemberus-gaap:CommonClassBMember2020-05-012020-07-310001734722us-gaap:ConvertiblePreferredStockMemberus-gaap:CommonClassAMember2021-02-012021-07-310001734722us-gaap:ConvertiblePreferredStockMemberus-gaap:CommonClassBMember2021-02-012021-07-310001734722us-gaap:ConvertiblePreferredStockMemberus-gaap:CommonClassAMember2020-02-012020-07-310001734722us-gaap:ConvertiblePreferredStockMemberus-gaap:CommonClassBMember2020-02-012020-07-310001734722us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonClassAMember2021-02-012021-07-310001734722us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonClassBMember2021-02-012021-07-310001734722us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonClassAMember2020-02-012020-07-310001734722us-gaap:RestrictedStockUnitsRSUMemberus-gaap:CommonClassBMember2020-02-012020-07-310001734722us-gaap:EmployeeStockOptionMemberus-gaap:CommonClassAMember2021-02-012021-07-310001734722us-gaap:EmployeeStockOptionMemberus-gaap:CommonClassBMember2021-02-012021-07-310001734722us-gaap:EmployeeStockOptionMemberus-gaap:CommonClassAMember2020-02-012020-07-310001734722us-gaap:EmployeeStockOptionMemberus-gaap:CommonClassBMember2020-02-012020-07-310001734722us-gaap:CommonClassAMemberpath:SharesSubjectToRepurchaseFromRestrictedStockAwardsAndEarlyExercisedStockOptionsMember2021-02-012021-07-310001734722us-gaap:CommonClassBMemberpath:SharesSubjectToRepurchaseFromRestrictedStockAwardsAndEarlyExercisedStockOptionsMember2021-02-012021-07-310001734722us-gaap:CommonClassAMemberpath:SharesSubjectToRepurchaseFromRestrictedStockAwardsAndEarlyExercisedStockOptionsMember2020-02-012020-07-310001734722us-gaap:CommonClassBMemberpath:SharesSubjectToRepurchaseFromRestrictedStockAwardsAndEarlyExercisedStockOptionsMember2020-02-012020-07-310001734722us-gaap:EmployeeStockMemberus-gaap:CommonClassAMember2021-02-012021-07-310001734722us-gaap:EmployeeStockMemberus-gaap:CommonClassBMember2021-02-012021-07-310001734722us-gaap:EmployeeStockMemberus-gaap:CommonClassAMember2020-02-012020-07-310001734722us-gaap:EmployeeStockMemberus-gaap:CommonClassBMember2020-02-012020-07-310001734722us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMemberus-gaap:CommonClassAMember2021-03-012021-03-310001734722us-gaap:SubsequentEventMemberpath:ExecutivesAndEmployeesMember2021-08-232021-08-230001734722srt:WeightedAverageMemberus-gaap:SubsequentEventMemberpath:ExecutivesAndEmployeesMember2021-08-232021-08-23
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________________________________
FORM 10-Q
___________________________________________
(Mark One)
| | | | | |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended July 31, 2021
OR
| | | | | |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ________ to ________
Commission File Number: 001-40348
___________________________________________
UiPath, Inc.
(Exact Name of Registrant as Specified in its Charter)
___________________________________________
| | | | | |
Delaware | 47-4333187 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
90 Park Ave, 20th Floor New York, New York | 10016 |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (844) 432-0455
___________________________________________
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Class A common stock, par value $0.00001 per share | | PATH | | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | | | | | | | | | |
Large accelerated filer | ☐ | | Accelerated filer | ☐ |
| | | | |
Non-accelerated filer | ☒ | | Smaller reporting company | ☐ |
| | | | |
Emerging growth company | ☒ | | | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of September 3, 2021, the registrant had 431,082,559 shares of Class A common stock and 82,452,748 shares of Class B common stock, each with a par value of $0.00001 per share, outstanding.
Table of Contents
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, about UiPath, Inc. and its consolidated subsidiaries (“UiPath,” the “Company,” “we,” “us,” or “our”) and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q, including statements regarding our future results of operations or financial condition, business strategy, and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” or the negative of these words or other similar terms or expressions. These forward-looking statements include, but are not limited to, statements concerning the following:
•our expectations regarding our annualized renewal run-rate, or ARR, revenue, expenses, and other operating results;
•our ability to acquire new customers and successfully retain existing customers;
•our ability to increase the number of users who access our platform and the number of automations built on our platform by our existing customers;
•our ability to effectively manage our growth and achieve or maintain profitability;
•future investments in our business, our anticipated capital expenditures, and our estimates regarding our capital requirements;
•the costs and success of our marketing efforts and our ability to maintain and enhance our brand;
•our growth strategies, including any further expansion into the top 25 countries as measured by gross domestic product;
•the estimated addressable market opportunity for our platform and automation generally;
•our reliance on key personnel and our ability to attract and retain highly-qualified personnel;
•our ability to obtain, maintain, protect, and enforce our intellectual property rights and any costs associated therewith;
•the effect of global events, such as the COVID-19 pandemic or other public health crises, on our business, industry, and the global economy;
•our ability to compete effectively with existing competitors and new market entrants; and
•the size and growth rates of the markets in which we compete.
You should not rely on forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Quarterly Report on Form 10-Q primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, and operating results. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors described in the section titled “Risk Factors” and elsewhere in this Quarterly Report on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report on Form 10-Q. The results, events, and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements. In addition, statements that “we believe,” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information available to us as of the date of this Quarterly Report on Form 10-Q. While we believe that information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive
inquiry into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements.
The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments.
PART I—FINANCIAL INFORMATION
Item 1. Financial Statements.
UiPath, Inc.
Condensed Consolidated Balance Sheets
Amounts in thousands except per share data
(unaudited) | | | | | | | | | | | |
| As of |
| July 31, 2021 | | January 31, 2021 |
ASSETS | | | |
Current assets | | | |
Cash and cash equivalents | $ | 1,826,424 | | | $ | 357,690 | |
Restricted cash, current | — | | | 7,000 | |
Marketable securities | 70,140 | | | 102,828 | |
Accounts receivable, net of allowance for doubtful accounts of $2,158 and $2,879, respectively | 138,945 | | | 172,286 | |
Contract assets, current | 53,555 | | | 34,221 | |
Deferred contract acquisition costs, current | 18,142 | | | 10,653 | |
Prepaid expenses and other current assets | 51,886 | | | 49,752 | |
Total current assets | 2,159,092 | | | 734,430 | |
Restricted cash, non-current | — | | | 6,500 | |
Contract assets, non-current | 2,537 | | | 2,085 | |
Deferred contract acquisition costs, non-current | 58,289 | | | 32,553 | |
Property and equipment, net | 14,728 | | | 14,822 | |
Operating lease right-of-use assets | 16,302 | | | 17,260 | |
Intangible assets, net | 18,866 | | | 10,191 | |
Goodwill | 55,193 | | | 28,059 | |
Deferred tax asset, non-current | 7,927 | | | 8,118 | |
Other assets, non-current | 14,947 | | | 12,443 | |
Total assets | $ | 2,347,881 | | | $ | 866,461 | |
LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS' EQUITY (DEFICIT) | | | |
Current liabilities | | | |
Accounts payable | $ | 2,874 | | | $ | 6,682 | |
Accrued expenses and other current liabilities | 60,558 | | | 36,660 | |
Accrued compensation and employee benefits | 75,628 | | | 110,736 | |
Deferred revenues, current | 235,484 | | | 211,078 | |
Total current liabilities | 374,544 | | | 365,156 | |
Deferred revenues, non-current | 54,465 | | | 61,325 | |
Operating lease liabilities, non-current | 12,328 | | | 14,152 | |
Other liabilities, non-current | 7,591 | | | 7,564 | |
Total liabilities | 448,928 | | | 448,197 | |
Commitments and contingencies (Note 11) | | | |
Convertible preferred stock, $0.00001 par value per share, 0 and 297,973 shares authorized as of July 31, 2021 and January 31, 2021, respectively; 0 and 294,257 shares issued and outstanding as of July 31, 2021 and January 31, 2021, respectively | — | | | 1,221,968 | |
Stockholders' equity (deficit) | | | |
Preferred stock, $0.00001 par value per share, 20,000 and 0 shares authorized as of July 31, 2021 and January 31, 2021, respectively; 0 shares issued and outstanding as of July 31, 2021 and January 31, 2021 | — | | | — | |
Class A common stock, $0.00001 par value per share, 2,000,000 and 581,000 shares authorized as of July 31, 2021 and January 31, 2021, respectively; 430,793 and 75,177 shares issued and outstanding as of July 31, 2021 and January 31, 2021, respectively | 4 | | | 1 | |
Class B common stock, $0.00001 par value per share, 115,741 shares authorized as of July 31, 2021 and January 31, 2021; 82,453 and 110,653 shares issued and outstanding as of July 31, 2021 and January 31, 2021, respectively | 1 | | | 1 | |
Additional paid-in capital | 3,213,595 | | | 179,175 | |
Accumulated other comprehensive loss | (4,598) | | | (12,521) | |
Accumulated deficit | (1,310,049) | | | (970,360) | |
Total stockholders’ equity (deficit) | 1,898,953 | | | (803,704) | |
Total liabilities, convertible preferred stock, and stockholders’ equity (deficit) | $ | 2,347,881 | | | $ | 866,461 | |
The accompanying notes are an integral part of these condensed consolidated financial statements.
UiPath, Inc.
Condensed Consolidated Statements of Operations
Amounts in thousands except per share data
(unaudited)
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended July 31, | | Six Months Ended July 31, |
| 2021 | | 2020 | | 2021 | | 2020 |
Revenue: | | | | | | | |
Licenses | $ | 95,547 | | | $ | 79,513 | | | $ | 195,763 | | | $ | 143,272 | |
Maintenance and support | 90,319 | | | 51,932 | | | 167,961 | | | 95,128 | |
Services and other | 9,655 | | | 7,931 | | | 18,014 | | | 14,079 | |
Total revenue | 195,521 | | | 139,376 | | | 381,738 | | | 252,479 | |
Cost of revenue: | | | | | | | |
Licenses | 2,434 | | | 1,636 | | | 4,888 | | | 3,053 | |
Maintenance and support | 12,238 | | | 5,501 | | | 26,417 | | | 11,044 | |
Services and other | 20,922 | | | 7,561 | | | 53,299 | | | 14,239 | |
Total cost of revenue | 35,594 | | | 14,698 | | | 84,604 | | | 28,336 | |
Gross profit | 159,927 | | | 124,678 | | | 297,134 | | | 224,143 | |
Operating expenses: | | | | | | | |
Sales and marketing | 144,268 | | | 90,331 | | | 350,019 | | | 181,262 | |
Research and development | 57,646 | | | 26,541 | | | 150,686 | | | 53,270 | |
General and administrative | 55,834 | | | 24,834 | | | 130,249 | | | 51,510 | |
Total operating expenses | 257,748 | | | 141,706 | | | 630,954 | | | 286,042 | |
Operating loss | (97,821) | | | (17,028) | | | (333,820) | | | (61,899) | |
Interest income | 766 | | | 77 | | | 1,707 | | | 607 | |
Other (expense) income, net | (1,225) | | | 24,010 | | | (4,443) | | | 16,173 | |
(Loss) income before income taxes | (98,280) | | | 7,059 | | | (336,556) | | | (45,119) | |
Provision for income taxes | 1,746 | | | 2,072 | | | 3,133 | | | 2,734 | |
Net (loss) income | $ | (100,026) | | | $ | 4,987 | | | $ | (339,689) | | | $ | (47,853) | |
Undistributed earnings attributable to participating securities | — | | | 4,987 | | | — | | | — | |
Net loss attributable to common stockholders, basic and diluted | $ | (100,026) | | | $ | — | | | $ | (339,689) | | | $ | (47,853) | |
Net loss per share attributable to common stockholders, basic and diluted | $ | (0.19) | | | $ | — | | | $ | (0.91) | | | $ | (0.30) | |
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted | 526,512 | | | 162,914 | | | 373,488 | | | 160,980 | |
The accompanying notes are an integral part of these condensed consolidated financial statements.
UiPath, Inc.
Condensed Consolidated Statements of Comprehensive Loss
Amounts in thousands
(unaudited)
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended July 31, | | Six Months Ended July 31, |
| 2021 | | 2020 | | 2021 | | 2020 |
Net (loss) income | $ | (100,026) | | | $ | 4,987 | | | $ | (339,689) | | | $ | (47,853) | |
Other comprehensive income (loss), net of tax: | | | | | | | |
Unrealized gain on available-for-sale marketable securities, net | 36 | | | — | | | 9 | | | — | |
Foreign currency translation adjustments | 3,660 | | | (23,942) | | | 7,914 | | | (15,629) | |
Other comprehensive income (loss), net | 3,696 | | | (23,942) | | | 7,923 | | | (15,629) | |
Comprehensive loss | $ | (96,330) | | | $ | (18,955) | | | $ | (331,766) | | | $ | (63,482) | |
The accompanying notes are an integral part of these condensed consolidated financial statements.
UiPath, Inc.
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit)
Amounts in thousands
(unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Convertible Preferred Stock | | | Common Stock | | Additional Paid-in Capital Amount | | Accumulated Other Comprehensive Income (Loss) Amount | | Accumulated Deficit Amount | | Total Stockholders’ (Deficit) Equity Amount |
| | | Class A | | Class B | | | | |
| Shares | | Amount | | | Shares | | Amount | | Shares | | Amount | | | | |
Balance as of January 31, 2021 | 294,257 | | | $ | 1,221,968 | | | | 75,177 | | | $ | 1 | | | 110,653 | | | $ | 1 | | | $ | 179,175 | | | $ | (12,521) | | | $ | (970,360) | | | $ | (803,704) | |
Issuance of convertible preferred stock, net of issuance costs | 12,043 | | | 749,836 | | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | |
Conversion of convertible preferred stock to common stock upon initial public offering | (306,300) | | | (1,971,804) | | | | 306,300 | | | 3 | | | — | | | — | | | 1,971,801 | | | — | | | — | | | 1,971,804 | |
Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and other issuance costs | — | | | — | | | | 13,000 | | | — | | | — | | | — | | | 687,903 | | | — | | | — | | | 687,903 | |
Conversion of shares of Class B common stock into shares of Class A common stock | — | | | — | | | | 28,200 | | | — | | | (28,200) | | | — | | | — | | | — | | | — | | | — | |
Shares issued as consideration for business acquisition | — | | | — | | | | 543 | | | — | | | — | | | — | | | 30,446 | | | — | | | — | | | 30,446 | |
Issuance of common stock upon exercise of stock options | — | | | — | | | | 1,881 | | | — | | | — | | | — | | | 3,114 | | | — | | | — | | | 3,114 | |
Vesting of early exercised stock options | — | | | — | | | | — | | | — | | | — | | | — | | | 1,646 | | | — | | | — | | | 1,646 | |
Issuance of common stock upon settlement of restricted stock units | — | | | — | | | | 389 | | | — | | | — | | | — | | | — | | | — | | | — | | | — | |
Tax withholdings on settlement of restricted stock units | — | | | — | | | | (164) | | | — | | | — | | | — | | | (9,218) | | | — | | | — | | | (9,218) | |
Stock-based compensation expense | — | | | — | | | | — | | | — | | | — | | | — | | | 252,986 | | | — | | | — | | | 252,986 | |
Other comprehensive income, net of tax | — | | | — | | | | — | | | — | | | — | | | — | | | — | | | 4,227 | | | — | | | 4,227 | |
Net loss | — | | | — | | | | — | | | — | | | — | | | — | | | — | | | — | | | (239,663) | | | (239,663) | |
Balance as of April 30, 2021 | — | | | $ | — | | | | 425,326 | | | $ | 4 | | | 82,453 | | | $ | 1 | | | $ | 3,117,853 | | | $ | (8,294) | | | $ | (1,210,023) | | | $ | 1,899,541 | |
| | | | | | | | | | | | | | | | | | | | |
Shares issued as consideration for business acquisition | — | | | — | | | | — | | | — | | | — | | | — | | | 21 | | | — | | | — | | | 21 | |
Issuance of common stock upon exercise of stock options | — | | | — | | | | 2,993 | | | — | | | — | | | — | | | 3,537 | | | — | | | — | | | 3,537 | |
Vesting of early exercised stock options | — | | | — | | | | — | | | — | | | — | | | — | | | 615 | | | — | | | — | | | 615 | |
Issuance of common stock upon settlement of restricted stock units | — | | | — | | | | 2,492 | | | — | | | — | | | — | | | — | | | — | | | — | | | — | |
Tax withholdings on settlement of restricted stock units | — | | | — | | | | (18) | | | — | | | — | | | — | | | (1,175) | | | — | | | — | | | (1,175) | |
Stock-based compensation expense | — | | | — | | | | — | | | — | | | — | | | — | | | 92,744 | | | — | | | — | | | 92,744 | |
Other comprehensive income, net of tax | — | | | — | | | | — | | | — | | | — | | | — | | | — | | | 3,696 | | | — | | | 3,696 | |
Net loss | — | | | — | | | | — | | | — | | | — | | | — | | | — | | | — | | | (100,026) | | | (100,026) | |
Balance as of July 31, 2021 | — | | | $ | — | | | | 430,793 | | | $ | 4 | | | 82,453 | | | $ | 1 | | | $ | 3,213,595 | | | $ | (4,598) | | | $ | (1,310,049) | | | $ | 1,898,953 | |
UiPath, Inc.
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit)
Amounts in thousands
(unaudited)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Convertible Preferred Stock | | | Common Stock | | Additional Paid-in Capital Amount | | Accumulated Other Comprehensive Income (Loss) Amount | | Accumulated Deficit Amount | | Total Stockholders Deficit Amount |
| | | Class A | | Class B | | | | |
| Shares | | Amount | | | Shares | | Amount | | Shares | | Amount | | | | |
Balance as of January 31, 2020 | 282,108 | | | $ | 996,389 | | | | 41,883 | | | $ | — | | | 115,741 | | | $ | 1 | | | $ | 72,229 | | | $ | 6,226 | | | $ | (877,967) | | | $ | (799,511) | |
Issuance of common stock upon exercise of stock options | — | | | — | | | | 2,166 | | | — | | | — | | | — | | | 536 | | | — | | | — | | | 536 | |
Compensation expense related to secondary transactions | — | | | — | | | | — | | | — | | | — | | | — | | | 35 | | | — | | | — | | | 35 | |
Stock-based compensation expense | — | | | — | | | | — | | | — | | | — | | | — | | | 8,166 | | | — | | | — | | | 8,166 | |
Other comprehensive income, net of tax | — | | | — | | | | — | | | — | | | — | | | — | | | — | | | 8,313 | | | — | | | 8,313 | |
Net loss | — | | | — | | | | — | | | — | | | — | | | — | | | — | | | — | | | (52,840) | | | (52,840) | |
Balance as of April 30, 2020 | 282,108 | | | $ | 996,389 | | | | 44,049 | | | $ | — | | | 115,741 | | | $ | 1 | | | $ | 80,966 | | | $ | 14,539 | | | $ | (930,807) | | | $ | (835,301) | |
Issuance of convertible preferred stock, net of issuance costs | 12,149 | | | 225,579 | | | | — | | | — | | | — | | | — | | | — | | | — | | | — | | | — | |
Issuance of common stock upon exercise of stock options | — | | | — | | | | 7,600 | | | 1 | | | — | | | — | | | 2,183 | | | — | | | — | | | 2,184 | |
Stock-based compensation expense | — | | | — | | | | — | | | — | | | — | | | — | | | 8,829 | | | — | | | — | | | 8,829 | |
Other comprehensive loss, net of tax | — | | | — | | | | — | | | — | | | — | | | — | | | — | | | (23,942) | | | — | | | (23,942) | |
Net income | — | | | — | | | | — | | | — | | | — | | | — | | | — | | | — | | | 4,987 | | | 4,987 | |
Balance as of July 31, 2020 | 294,257 | | | $ | 1,221,968 | | | | 51,649 | | | $ | 1 | | | 115,741 | | | $ | 1 | | | $ | 91,978 | | | $ | (9,403) | | | $ | (925,820) | | | $ | (843,243) | |
The accompanying notes are an integral part of these condensed consolidated financial statements.
UiPath, Inc.
Condensed Consolidated Statements of Cash Flows
Amounts in thousands
(unaudited) | | | | | | | | | | | |
| Six Months Ended July 31, |
| 2021 | | 2020 |
Cash flows from operating activities | | | |
Net loss | $ | (339,689) | | | $ | (47,853) | |
Adjustments to reconcile net loss to net cash used in operating activities: | | | |
Depreciation and amortization | 6,966 | | | 6,264 | |
Amortization of deferred contract acquisition costs | 10,971 | | | 18,991 | |
Amortization of deferred loan cost | 133 | | | — | |
Net amortization of premium on marketable securities | 867 | | | — | |
Stock-based compensation expense | 343,448 | | | 17,030 | |
Amortization of operating lease right-of-use assets | 3,580 | | | 3,708 | |
(Benefit from) provision for bad debt | (659) | | | 247 | |
Deferred income taxes | (134) | | | (10) | |
Changes in operating assets and liabilities: | | | |
Accounts receivable | 32,961 | | | (17,740) | |
Contract assets | (20,355) | | | (13,955) | |
Deferred contract acquisition costs | (44,946) | | | (18,516) | |
Prepaid expenses and other assets | (4,340) | | | 2,326 | |
Accounts payable | (3,663) | | | 1,414 | |
Accrued expense and other liabilities | 8,484 | | | 4,127 | |
Accrued compensation and employee benefits | (32,686) | | | 7,192 | |
Operating lease liabilities, net | (3,698) | | | (4,097) | |
Deferred revenue | 19,237 | | | 44,934 | |
Net cash (used in) provided by operating activities | (23,523) | | | 4,062 | |
Cash flows from investing activities | | | |
Purchases of marketable securities | (94,157) | | | — | |
Sales of marketable securities | 89,383 | | | — | |
Maturities of marketable securities | 36,605 | | | — | |
Purchases of property and equipment | (3,641) | | | (587) | |
Capitalization of software development costs | (771) | | | — | |
Payment related to business acquisition, net of cash acquired | (5,498) | | | (1,000) | |
Net cash provided by (used in) investing activities | 21,921 | | | (1,587) | |
Cash flows from financing activities | | | |
Proceeds from initial public offering, net of underwriting discounts and commissions | 692,369 | | | — | |
Payments of initial public offering costs | (3,734) | | | — | |
Proceeds from issuance of convertible preferred stock | 750,000 | | | 225,903 | |
Payments of issuance costs for convertible preferred stock | (164) | | | (324) | |
Proceeds from exercise of stock options | 6,651 | | | 2,719 | |
Payments of tax withholdings on net settlement of equity awards | (9,554) | | | — | |
Net receipts of tax withholdings on sell-to-cover equity award transactions | 9,483 | | | — | |
Proceeds from employee stock purchase plan contributions | 6,902 | | | — | |
Proceeds from credit facility | — | | | 78,587 | |
Repayments of credit facility | — | | | (78,587) | |
Net cash provided by financing activities | 1,451,953 | | | 228,298 | |
Effect of exchange rate changes | 4,883 | | | (14,067) | |
Net increase in cash, cash equivalents and restricted cash | 1,455,234 | | | 216,706 | |
Cash, cash equivalents and restricted cash - beginning of period | 371,190 | | | 234,131 | |
Cash, cash equivalents and restricted cash - end of period | $ | 1,826,424 | | | $ | 450,837 | |
Supplemental disclosure of cash flow information | | | |
Cash paid for interest | $ | 313 | | | $ | 1,247 | |
Cash paid for income taxes | 4,035 | | | 1,697 | |
Supplemental disclosure of non-cash investing and financing activities | | | |
Stock-based compensation capitalized for software development | $ | 2,282 | | | $ | — | |
Value of shares issued in payment of business acquisition | 30,467 | | | — | |
Reduction in accrued expenses and other liabilities for vesting of early exercised stock options | 2,261 | | | — | |
Tax withholdings on net settlement of restricted stock units, accrued and unpaid | 996 | | | — | |
Deferred payments related to business acquisitions | — | | | 18,984 | |
The accompanying notes are an integral part of these consolidated financial statements.
UiPath, Inc.
Notes to Condensed Consolidated Financial Statements
(unaudited)
1. Organization and Description of Business
Description of Business
UiPath, Inc. (the “Company,” “we,” “us,” or “our”) was incorporated in Delaware in June 2015 and is headquartered in New York. We offer an end-to-end automation platform which provides a range of robotic process automation (“RPA”) solutions via a suite of interrelated software offerings (the “RPA Software”), including:
•UiPath Studio (“Studio”) – Studio is an easy to use, drag-and-drop development platform designed for RPA developers looking to build complex process automations with built-in governance capabilities. Studio features robust debugging tools, application programming interface (“API”) automation, wizards to automate desktop or web applications, the ability to leverage custom code, and a simple way to integrate machine learning models into production workflows.
•UiPath Robots (“Robots”) – Robots emulate human behavior to execute the processes built in Studio. Robots can work unattended (without human supervision in any environment, virtual or not) or attended (with a human triggering the process).
•UiPath Orchestrator (“Orchestrator”) – Orchestrator tracks and logs Robot activity, along with what people do in tandem, to maintain strict compliance and governance through dashboards and visualization tools. Orchestrator enables seamless integration with our marketplace, which is UiPath’s database of vetted, pre-built, and reusable automation activities and components, software, and third-party products, giving users the opportunity to leverage our global RPA community and deploy automations across cloud, on-premises, and hybrid environments.
We provide our offerings by selling a software license to customers, which allows customers to use the RPA Software on their own hardware (i.e., term and perpetual licenses) or in the cloud. Additionally, we offer maintenance and support, training, and implementation services to our customers to facilitate their adoption of the RPA Software.
We have legal presence in 29 countries, with our principal operations in the United States, Romania, and Japan.
Initial Public Offering
On April 23, 2021, we completed our initial public offering (“IPO”), in which we issued and sold 13.0 million shares of our Class A common stock at a public offering price of $56.00 per share, including 3.6 million shares of Class A common stock pursuant to the exercise in full of the underwriters’ option to purchase additional shares. We received net proceeds of $692.4 million after deducting underwriting discounts and commissions of $35.6 million. In addition, the selling stockholders, named in our final prospectus that forms a part of the Registration Statement on Form S-1 (File No. 333-254738) for the IPO filed with the Securities and Exchange Commission (“SEC”) pursuant to Rule 424(b)(4) on April 21, 2021 (the “Final Prospectus”), sold an additional 14.5 million shares, for which we did not receive any proceeds. In connection with the IPO, all shares of convertible preferred stock then outstanding automatically converted into an aggregate of 306.3 million shares of Class A common stock.
As of January 31, 2021, $1.5 million of deferred offering costs, which consisted primarily of accounting, legal and other fees related to the IPO, were capitalized within other assets, non-current in the condensed consolidated balance sheets. Upon the consummation of the IPO, $4.5 million of deferred offering costs were reclassified into stockholders’ equity as an offset to IPO proceeds. Deferred offering costs were paid in full as of July 31, 2021.
UiPath, Inc.
Notes to Condensed Consolidated Financial Statements (Continued)
(unaudited)
2. Summary of Significant Accounting Policies
The Company’s significant accounting policies are discussed in Note 2, Summary of Significant Accounting Policies, in the Notes to Consolidated Financial Statements in the Final Prospectus. There have been no significant changes to these policies during the six months ended July 31, 2021.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable regulations of the SEC regarding interim financial reporting, and include the financial statements of UiPath, Inc. and its wholly owned subsidiaries in which we hold a controlling financial interest or are the primary beneficiary. Intercompany transactions and accounts have been eliminated in consolidation.
As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. These financial statements have been prepared on the same basis as the Company’s annual financial statements and, in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for the fair statement of the Company’s financial information. These interim results are not necessarily indicative of the results to be expected for the fiscal year ending January 31, 2022 or for any other interim period or for any other future year. The accompanying unaudited condensed consolidated financial statements and related financial information should be read in conjunction with the audited consolidated financial statements and the related notes thereto for the fiscal year ended January 31, 2021 contained in the Final Prospectus.
Fiscal Year
Our fiscal year ends on January 31. References to fiscal year 2022, for example, refer to the fiscal year ending January 31, 2022.
Use of Estimates
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the date of the condensed consolidated financial statements and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, revenue recognition, estimated expected benefit period for deferred contract acquisition costs, allowance for doubtful accounts, fair value of financial assets and liabilities including accounting and fair value of derivatives, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (“ROU”) assets, incremental borrowing rates for operating leases, amount of stock-based compensation expense including determination of fair value of common stock prior to the IPO, timing and amount of contingencies, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions.
Foreign Currency
The functional currency of our non-U.S. subsidiaries is the local currency. Asset and liability balances denominated in non-U.S. dollar currencies are translated into U.S. dollars using period-end exchange rates, while revenue and expenses are translated using the average monthly exchange rates. Differences are included in stockholders’ equity (deficit) as a component of accumulated other comprehensive income (loss). Financial assets and liabilities denominated in currencies other than the functional currency are recorded at the exchange rate at the time of the transaction and subsequent gains and losses related to changes in the foreign currency are included in other (expense) income, net in the condensed consolidated statements of operations. For the three months ended July 31, 2021 and 2020, we recognized transaction losses of $2.3 million and transaction gains of $24.3 million, respectively. For the six months ended July 31, 2021 and 2020, we recognized transaction losses of $5.2 million and transaction gains of $17.0 million, respectively.
UiPath, Inc.
Notes to Condensed Consolidated Financial Statements (Continued)
(unaudited)
Derivative Financial Instruments
Since fiscal year 2021, we use derivative financial instruments, such as foreign currency forward contracts, to manage foreign currency exposures. We account for our derivative financial instruments as either assets or liabilities and carry them at fair value. These foreign currency contracts are not designated and do not qualify as hedging instruments, as defined by Accounting Standards Codification (“ASC”) 815, Derivatives and Hedging.
As of July 31, 2021 and January 31, 2021, derivative financial instruments with a fair value totaling $0.1 million and $(0.6) million, respectively, were recorded in prepaid expenses and other current assets, and accrued expenses and other current liabilities within the condensed consolidated balance sheets, respectively. We record changes in the fair value of these derivatives as a component of other (expense) income net, in the condensed consolidated statements of operations. The notional amount of foreign currency forward contracts outstanding was $123.0 million and $138.6 million as of July 31, 2021 and January 31, 2021, respectively. The net gain associated with foreign currency forward contracts was $1.4 million and $2.0 million for the three and six months ended July 31, 2021. We did not have foreign currency forward contracts during the three and six months ended July 31, 2020.
Concentration of Risks
Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities, and accounts receivable. We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where our deposits, at times, exceed the Federal Deposit Insurance Corporation (“FDIC”) limits. As of July 31, 2021 and January 31, 2021, 99% and 92%, respectively, of our cash, cash equivalents, and restricted cash were concentrated in the United States, European Union (“EU”) countries, and Japan.
We extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures.
Significant customers are those which represent 10% or more of our total revenue for the period or accounts receivable at the balance sheet date. For the three and six months ended July 31, 2021 and 2020, no single customer accounted for 10% or more of our total revenue. As of July 31, 2021, one customer accounted for 13% of our accounts receivable. As of January 31, 2021, no single customer accounted for 10% or more of our accounts receivable.
Revenue Recognition
We derive our revenue from the sale of licenses for use of our proprietary software, maintenance and support for licenses, right to access certain software products that we host (i.e., software as a service (“SaaS”)), and professional services. In accordance with ASC 606, Revenue from Contracts with Customers, revenue is recognized when or as a customer obtains control of the promised goods and services. The amount of revenue recognized reflects the consideration to which we expect to be entitled in exchange for those goods or services. To achieve the core principle of ASC 606, we apply the following five steps:
1.Identification of the contract, or contracts, with the customer;
2.Identification of the performance obligations in the contract;
3.Determination of the transaction price;
4.Allocation of the transaction price to the performance obligations in the contract; and
5.Recognition of the revenue when, or as, a performance obligation is satisfied.
Our significant performance obligations and our application of ASC 606 to each of those performance obligations are discussed in further detail below.
UiPath, Inc.
Notes to Condensed Consolidated Financial Statements (Continued)
(unaudited)
Licenses
We primarily sell term licenses, including through hybrid offerings (comprised of a term license, maintenance and support, and SaaS), which provide customers the right to use software for a specified period of time, and perpetual licenses, which provide customers the right to use software for an indefinite period of time. For both types of licenses, revenue is recognized at the point in time at which the customer is able to use and benefit from the software, which is generally upon delivery to the customer or upon commencement of the renewal term. For licenses revenue, we generally invoice when the license(s) are provided.
Maintenance and Support
We generate maintenance and support revenue through the provision of technical support services and the provision of unspecified updates and upgrades on a when-and-if-available basis for both term and perpetual license arrangements. Maintenance and support for perpetual licenses is renewable, generally on an annual basis, at the option of the customer. Maintenance and support represents a stand-ready obligation for which revenue is recognized ratably over the term of the arrangement. For maintenance and support services, we generally invoice when the associated license(s) are provided and upon renewals. Maintenance and support also includes revenue from the SaaS component of our hybrid offerings and revenue from our SaaS products, as such revenue constituted an immaterial portion of total revenue for the three and six months ended July 31, 2021 and 2020. The SaaS component of our hybrid offerings and our SaaS products are stand-ready obligations to provide access to our products, and the related revenue is recognized on a ratable basis over the contractual period of the arrangement, as control of the services is transferred to the customer.
Services and Other
Revenue from services and other consists of fees associated with professional services for process automation, customer education and training services. A substantial majority of our professional services contracts are recognized on a time and materials basis, and the related revenue is recognized as the services are rendered. For professional services, we invoice as the work is incurred or in advance.
Material Rights
Contracts with customers may include material rights, which are also performance obligations. Material rights primarily arise when the contract gives the customer the right to renew or to receive products or services at a greater discount in the future. The revenue associated with material rights is recognized at the earlier of the time of exercise or expiration of the customer’s rights.
Contracts with Multiple Performance Obligations
Most contracts with customers contain multiple performance obligations. The transaction price is allocated to the separate performance obligations on a relative stand-alone selling price (“SSP”) basis. When possible, we determine our SSP by reference to observable prices of our products and services in standalone sales. When we do not have such observable prices, we maximize the use of observable inputs when estimating the SSP; such observable inputs include historical contract pricing and industry pricing data available to the public. Our SSP reflects the amount we would charge for each performance obligation if it were sold separately in a standalone sale to similar customers in similar circumstances.
Other Policies and Judgments
Payment terms and conditions vary by contract type, although terms generally require payment within 30 to 60 days of the invoice date. In certain arrangements, we receive payment from a customer either before or after the performance obligation has been satisfied; however, our contracts do not contain a significant financing component. The primary purpose of our invoicing terms is to provide customers with simplified and predictable ways of purchasing our products and services, not to receive financing from our customers or to provide customers with financing. We apply the practical expedient in ASC 606 and do not evaluate payment terms of one year or less for the existence of a significant financing component. Revenue is recorded net of sales tax. We generally do not offer a right of refund in our contracts.
UiPath, Inc.
Notes to Condensed Consolidated Financial Statements (Continued)
(unaudited)
Contract Balances
Contract assets consist of unbilled accounts receivable, which occur when a right to consideration for our performance under the customer contract occurs before invoicing the customer. Accounts receivable are recorded when the customer has been billed and the right to consideration is unconditional.
Contract liabilities consist of deferred revenue. Revenue is deferred when we invoice in advance of performance under a contract.
Deferred Contract Acquisition Costs
We defer sales commissions that are incremental to the acquisition of customer contracts. These costs are recorded as deferred contract acquisition costs on the condensed consolidated balance sheets. We determine whether costs should be deferred based on the terms of our sales compensation plans and based on whether the sales commissions are incremental to a customer contract and would not have occurred absent the customer contract.
During fiscal year 2021, sales commissions for renewals of subscription contracts were commensurate with the sales commissions paid for the acquisition of the initial subscription contract. Sales commissions paid upon the initial acquisition of a contract were therefore amortized over the contract term, while sales commissions paid related to renewal contracts were amortized over the renewal term. When the amortization period would have been one year or less, we applied the practical expedient in ASC 340-40, Other Assets, Deferred Costs, which allows for expensing of these costs as incurred.
At the end of fiscal year 2021, we approved a new sales incentive plan for fiscal year 2022 under which sales commissions for renewals of subscription contracts are not commensurate with the commissions paid on initial contracts. Under the new sales incentive plan, we defer incremental commissions related to initial contracts and amortize such costs over the expected period of benefit, which we determined to be five years. Renewal commissions are amortized over the renewal period except when such period is one year or less and the practical expedient applies.
Amortization is recognized consistently with the pattern of revenue recognition of the respective performance obligation to which the contract costs relate. Amortization of deferred contract acquisition costs is included in sales and marketing expense in the condensed consolidated statements of operations.
We periodically review deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. There were no impairment losses recorded during the three and six months ended July 31, 2021 and 2020.
Cost of Revenue
Licenses
Cost of licenses revenue consists of all direct costs to deliver our licenses to customers, amortization of software development costs, direct costs related to third party software resales, and amortization of acquired developed technology.
Maintenance and Support
Cost of maintenance and support revenue primarily consists of personnel-related expenses of our customer support and technical support teams, including salaries and bonuses, stock-based compensation expense, and employee benefit costs. Cost of maintenance and support revenue also includes third-party consulting services, hosting costs related to our hybrid and cloud-based products, amortization of acquired developed technology and capitalized software development costs related to cloud products, and allocated overhead. Overhead is allocated to cost of maintenance and support revenue based on applicable headcount. We recognize these expenses as they are incurred.
UiPath, Inc.
Notes to Condensed Consolidated Financial Statements (Continued)
(unaudited)
Services and Other
Cost of services and other revenue primarily consists of personnel-related expenses of our professional services team, including salaries and bonuses, stock-based compensation expense, and employee benefit costs. Cost of services and other revenue also includes third-party consulting services and allocated overhead. Overhead is allocated to cost of services and other revenue based on applicable headcount. We recognize these expenses as they are incurred.
Stock-Based Compensation
We recognize stock-based compensation expense in accordance with the provisions of ASC 718, Compensation - Stock Compensation. ASC 718 requires the measurement and recognition of compensation expense for all stock-based awards made to employees, directors, and non-employees based on the grant date fair value of the awards. The fair value of each stock option is estimated on the date of grant using the Black-Scholes pricing model. The fair value of employee stock purchase plan shares is estimated at the beginning of the relevant offering period using the Black-Scholes pricing model. The fair value of each restricted stock unit (“RSU”) and restricted stock award (“RSA”) is estimated based on the fair value of the Company’s Class A common stock on the grant date.
Prior to the IPO, the Company determined the fair value of its Class A common stock for financial reporting purposes as of each grant date based on numerous objective and subjective factors and management’s judgement. Subsequent to the IPO, the Company determines the fair value using the market closing price of its Class A common stock on the date of grant.
Stock-based compensation expense is included in cost of revenue and operating expenses within our condensed consolidated statements of operations based on the expense classification of the individual earning the award. The fair value of awards with only service-based vesting conditions is recognized as expense over the requisite service period on a straight-line basis. The fair value of awards that contain both service-based and performance-based vesting conditions, such as RSUs that were granted under the UiPath, Inc. 2018 Stock Plan (the “2018 Plan”) before our IPO, are recognized as expense using the accelerated attribution method once it is probable that the performance condition will be met.
Segment Information
Operating segments are defined as components of an entity for which discrete financial information is available and is regularly reviewed by the Chief Operating Decision Maker (“CODM”) in making decisions regarding resource allocation and performance assessment. The Company’s CODM is its Chief Executive Officer. The Company has determined that it has one operating and reportable segment as the CODM reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance.
Internal-Use Software
We capitalize costs incurred to implement cloud software and develop internal-use software pursuant to ASC 350-40, Internal Use Software. ASC 350-40 prescribes capitalization of costs incurred to develop internal-use software during the application development stage, costs incurred to develop or obtain software that allows for access to or conversion of old data by new systems, and costs incurred in connection with upgrades and enhancements to internal-use software if it is probable that such expenditures will result in additional functionality.
Costs incurred to implement a cloud computing arrangement that is a service contract are capitalized in our condensed consolidated financial statements in the same manner as other service costs and assets related to service contracts. These capitalized costs exclude training costs, project management costs, and data migration costs. Capitalized implementation costs are amortized on a straight-line basis over the terms of the associated hosting arrangements and are recorded under operating expenses in the same line item on the condensed consolidated statements of operations as the expense for fees for the associated hosting arrangement. Capitalized software implementation costs were $2.6 million and $2.6 million as of July 31, 2021 and January 31, 2021, respectively, and are recorded in other assets, non-current on our condensed consolidated balance sheets. Related amortization expense for the three months ended July 31, 2021 and 2020 was $0.2 million and $0.1 million,
UiPath, Inc.
Notes to Condensed Consolidated Financial Statements (Continued)
(unaudited)
respectively. Related amortization expense for the six months ended July 31, 2021 and 2020 was $0.4 million and $0.2 million, respectively.
Costs incurred to develop cloud offerings are capitalized and amortized on a straight-line basis over the product’s estimated useful life of five years and are included in cost of maintenance and support revenue on the condensed consolidated statements of operations. Capitalized costs include salaries, benefits, and stock-based compensation charges for employees that are directly involved in developing our cloud-based products. These capitalized costs are included in other assets, non-current on the condensed consolidated balance sheets and were $7.1 million and $4.4 million as of July 31, 2021 and January 31, 2021, respectively. Related amortization expense was $0.3 million and $0.1 million for the three months ended July 31, 2021 and 2020, respectively. Related amortization expense for the six months ended July 31, 2021 and 2020 was $0.5 million and $0.1 million, respectively.
Software Development Costs
We account for costs incurred to develop software to be licensed in accordance with ASC 985-20, Costs of Software to be Sold, Leased or Marketed. ASC 985-20 requires all costs incurred to establish technological feasibility to be expensed as they are incurred. Technological feasibility is established when the working model is complete. Costs incurred subsequent to establishing technological feasibility are capitalized until the product is available for general release to customers, at which point they are amortized on a product by product basis. Capitalized costs are included in other assets, non-current on the condensed consolidated balance sheets. These costs are amortized on a straight-line basis over the software’s estimated useful life of five years, and are included in cost of licenses revenue in the condensed consolidated statements of operations. Management evaluates the remaining useful life of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. Capitalized software development costs were $3.2 million and $2.9 million as of July 31, 2021 and January 31, 2021, respectively. Related amortization expense was $0.2 million and $0.2 million for the three months ended July 31, 2021 and 2020, respectively. Related amortization expense for the six months ended July 31, 2021 and 2020 was $0.3 million and $0.3 million, respectively.
Recently Adopted Accounting Pronouncements
As an “emerging growth company,” the Jumpstart Our Business Startups Act (“JOBS Act”) allows us to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. We have elected to use this extended transition period under the JOBS Act.
In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40). ASU No. 2020-06 simplifies accounting for convertible instruments by removing certain separation models required under current U.S. GAAP. ASU No. 2020-06 also removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, and it revises the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share for convertible instruments by using the if-converted method. We early adopted ASU No. 2020-06 on a retrospective basis on February 1, 2021, and the adoption did not have a material impact on our condensed consolidated financial statements.
Recently Issued Accounting Pronouncements
In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740)—Simplifying the Accounting for Income Taxes, which is intended to simplify various aspects related to accounting for income taxes. ASU No. 2019-12 simplifies the accounting for income taxes by removing certain exceptions associated with (i) intraperiod tax allocations, (ii) recognition of deferred tax liabilities for equity method investments of foreign subsidiaries, and (iii) the calculation of income taxes in an interim period when in a loss position within the framework of ASC 740. ASU No. 2019-12 also clarifies and amends existing guidance to improve consistent application. ASU No. 2019-12 will be effective for us beginning February 1, 2022, and for interim periods in fiscal
UiPath, Inc.
Notes to Condensed Consolidated Financial Statements (Continued)
(unaudited)
years beginning February 1, 2023. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, to amend the current accounting guidance which requires the measurement of all expected losses to be based on historical experience, current conditions, and reasonable and supportable forecasts. For trade receivables, contract assets, and other financial instruments, we will be required to use a forward-looking expected loss model that reflects probable losses rather than the incurred loss model for recognizing credit losses. ASU No. 2016-13 will be effective for us beginning February 1, 2023. Early adoption is permitted. We are currently evaluating the impact of this pronouncement on our condensed consolidated financial statements.
3. Revenue Recognition
Disaggregation of Revenue
The following tables present revenue by region, according to the location of those customers from which the revenue was generated (in thousands except percentages):
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended July 31, |
| 2021 | | 2020 |
| Amount | | Percentage of Revenue | | Amount | | Percentage of Revenue |
Americas (1) | $ | 89,266 | | | 46 | % | | $ | 61,541 | | | 44 | % |
Europe, Middle East, and Africa | 60,405 | | | 31 | % | | 39,483 | | | 28 | % |
Asia-Pacific (2) | 45,850 | | | 23 | % | | 38,352 | | | 28 | % |
Total revenue | $ | 195,521 | | | 100 | % | | $ | 139,376 | | | 100 | % |
(1)Revenue from the United States represented 42% and 41% of our total revenues for the three months ended July 31, 2021 and 2020, respectively.
(2)Revenue from Japan represented 12% and 15% of our total revenues for the three months ended July 31, 2021 and 2020, respectively.
| | | | | | | | | | | | | | | | | | | | | | | |
| Six Months Ended July 31, |
| 2021 | | 2020 |
| Amount | | Percentage of Revenue | | Amount | | Percentage of Revenue |
Americas (1) | $ | 173,892 | | | 46 | % | | $ | 102,894 | | | 41 | % |
Europe, Middle East, and Africa | 110,489 | | | 29 | % | | 76,163 | | | 30 | % |
Asia-Pacific (2) | 97,357 | | | 25 | % | | 73,422 | | | 29 | % |
Total revenue | $ | 381,738 | | | 100 | % | | $ | 252,479 | | | 100 | % |
(1)Revenue from the United States represented 41% and 37% of our total revenues for the six months ended July 31, 2021 and 2020, respectively.
(2)Revenue from Japan represented 14% and 17% of our total revenues for the six months ended July 31, 2021 and 2020, respectively.
Deferred Revenue
During the six months ended July 31, 2021 and 2020, we recognized $137.8 million and $82.0 million of revenue that was included in the deferred revenue balance as of January 31, 2021 and 2020, respectively.
Remaining Performance Obligations
Our remaining performance obligations are comprised of licenses, maintenance and support, and services and other revenue not yet delivered. As of July 31, 2021, the aggregate amount of transaction price allocated to remaining performance obligations was $519.9 million, which consists of $289.9 million of billed consideration and $230.0 million of unbilled consideration. Of this aggregate amount, we expect to recognize 62% as revenue over the next 12 months, and the remainder thereafter.
UiPath, Inc.
Notes to Condensed Consolidated Financial Statements (Continued)
(unaudited)
Deferred Contract Acquisition Costs
Our deferred contract acquisition costs are comprised of sales commissions that represent incremental costs to obtain customer contracts, and are determined based on sales compensation plans. Amortization of deferred contract acquisition costs was $6.1 million and $11.0 million for the three months ended July 31, 2021 and 2020, respectively, and $11.0 million and $19.0 million for the six months ended July 31, 2021 and 2020, respectively.
4. Marketable Securities
The following is a summary of our marketable securities (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | |
| As of July 31, 2021 |
| Amortized Cost | | Gross Unrealized Gains | | Gross Unrealized Losses | | Estimated Fair Value |
Commercial paper | $ | 23,738 | | | $ | — | | | $ | — | | | $ | 23,738 | |
Corporate bonds | 46,410 | | | — | | | (8) | | | 46,402 | |
Total marketable securities | $ | 70,148 | | | $ | — | | | $ | (8) | | | $ | 70,140 | |
| | | | | | | | | | | | | | | | | | | | | | | |
| As of January 31, 2021 |
| Amortized Cost | |